Differential distribution of somatostatin receptor subtypes in rat brain revealed by newly developed somatostatin analogs

https://doi.org/10.1016/0306-4522(91)90351-NGet rights and content

Abstract

Somatostatin receptor subtypes were labeled with the somatostatin analogs [125I]CGP 23996 and [125I]MK 678 and the distribution of these receptors in rat brain was investigated using quantitative autoradiographic techniques. [125I]CGP 23996 and [125I]MK 678 specifically label different populations of somatostatin receptors in rat brain. In a number of brain regions striking differences in the distribution of the somatostatin receptor subtypes labeled by each peptide were observed. High levels of binding sites for both [125I]CGP 23996 and [125I]MK 678 were present in the cerebral cortex, CA1 region and subiculum of the hippocampus. In contrast, high levels of [125I]MK 678 binding were found in the dentate gyrus of the hippocampus while few [125I]CGP 23996 binding sites were observed in this brain region. [125I]CGP 23996 binding was detected in the central region of the interpeduncular nucleus whereas the dorsal and lateral subnuclei of this brain area expressed mainly somatostatin receptors with high affinity for MK 678. The locus coeruleus and regions of the superior colliculus and hypothalamus selectively express [125I]MK 678-sensitive somatostatin receptors. Furthermore, limbic structures such as the lateral septum, the nucleus accumbens and ventromedial striatum had much higher levels of [125I]MK 678 binding sites than [125I]CGP 23996 binding sites. Differences in the expression of the somatostatin receptor subtypes were also detected in the substantia nigra. [125I]CGP 23996 binding was present in the pars reticulata but not the pars compacta whereas the reverse distribution for [125I]MK 678 binding sites was observed.

The differential distribution of [125I]CGP 23996 and [125I]MK 678 binding sites in rat brain supports the hypothesis that these peptides selectively label different somatostatin receptor subtypes in the central nervous system.

Reference (33)

  • ThermosK. et al.

    Biochemical properties of brain somatostatin receptors

    Neuroscience

    (1989)
  • WhitfordC. et al.

    Autoradiographic visualization of binding sites for3H-somatostatin in the rat brain

    Eur. J. Pharmac.

    (1987)
  • AmherdtM. et al.

    Selective binding of somatostatin-14 and somatostatin-28 to islet cells revealed by electron microscopic autoradiography

    J. clin. Invest.

    (1987)
  • BealM. et al.

    The effect of somatostatin on striatal catecholamines

    Neurosci. Lett.

    (1983)
  • BrazeauP. et al.

    Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone

    Science

    (1972)
  • BrownM. et al.

    Somatostatin-28 selective actions on the pancreatic beta-cells and brain

    Endocrinology

    (1981)
  • Cited by (111)

    • Long-lasting actions of somatostatin on pyramidal cell excitability in the mouse cingulate cortex

      2019, Neuroscience Letters
      Citation Excerpt :

      The cingulate cortex is part of the limbic system and contains a high density of somatostatin receptors (SSTRs; [1,2]).

    • Intra-ventral tegmental area microinjections of urotensin II modulate the effects of cocaine

      2015, Behavioural Brain Research
      Citation Excerpt :

      Thus, thorough examination of intra-VTA UII/URP effects on dopamine efflux in the NAc will need to be performed. The VTA and surrounding structures (e.g. interpeduncular nucleus and substantia nigra) express somatostatin receptors [30,48,58] that are known to be activated by high concentrations of UII [37]. In addition, the interpeduncular nucleus expresses the UIIR [10].

    View all citing articles on Scopus
    View full text